PRME FY 2025 Earnings — Prime Medicine, Inc. Revenue & Financial Results | Market Cap Arena

PRMEPrime Medicine, Inc.

$771M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+55.3% YoY

Gross Profit

$00.0% margin

Operating Income

-$208M-4498.1% margin

Net Income

-$201M-4342.4% margin

EPS (Diluted)

$-1.35

Cash Flow

Operating Cash Flow

-$163M

Free Cash Flow

-$167M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$343M

Total Liabilities

$222M

Stockholders' Equity

$121M

Cash & Equivalents

$63M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$3M	+55.3%
Gross Profit	$0	$3M	-100.0%
Operating Income	-$208M	-$202M	-2.9%
Net Income	-$201M	-$196M	-2.7%